157 results on '"Sadler, John H."'
Search Results
2. 61 - Physical, Psychosocial, and Vocational Rehabilitation of Patients Undergoing Long-Term Dialysis
3. Physical, Psychosocial, and Vocational Rehabilitation of Adult Dialysis Patients
4. Contributors
5. Quality assurance: Starting a program in dialysis
6. Frequency of patient-physician contact in chronic kidney disease care and achievement of clinical performance targets
7. Age-Dependent Enhancement of Influenza Vaccine Responses by Thymosin in Chronic Hemodialysis Patients
8. Accuracy of Patients' Reports of Comorbid Disease and Their Association With Mortality in ESRD
9. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis
10. Contributors
11. Physical, Psychosocial, and Vocational Rehabilitation of Adult Dialysis Patients
12. CONTRIBUTORS
13. Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease
14. Frequency of Sit-Down Patient Care Rounds, Attainment of Clinical Performance Targets, Hospitalization, and Mortality in Hemodialysis Patients
15. Frequency of Patient–Physician Contact and Patient Outcomes in Hemodialysis Care
16. Centers for Disease Control and Prevention: A Clinician's View of the Past, Present, and Future
17. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study
18. Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population: 1990-1996
19. "U" curve association of blood pressure and mortality in hemodialysis patients
20. Chapter 68 - Physical, Psychosocial, and Vocational Rehabilitation of Adult Dialysis Patients
21. Measuring and improving the health status of end stage renal disease patients
22. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study
23. Renal rehabilitation: Obstacles, progress, and prospects for the future
24. Effects of Acute and Repeated Oral Doses of[formula omitted]-Tagatose on Plasma Uric Acid in Normal and Diabetic Humans
25. Health Care Highlight: Measuring and Improving the Health Status of End Stage Renal Disease Patients
26. Capítulo 85 - Rehabilitación física, psicosocial y profesional de los pacientes adultos de diálisis
27. Race and access to erythropoietin by patients on hemodialysis
28. Association of Residual Urine Output With Mortality, Quality of Life, and Inflammation in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study
29. The 2009 Proposed Rule for Prospective ESRD Payment: Perspectives From a Not-for-Profit Small Dialysis Organization
30. RED BLOOD CELL DESTRUCTION IN HEMODIALYSIS
31. With the Pursuit of Quality Comes a Retreat From Personal Care: The Path of Medical Practice and Dialysis Care in America
32. Choices for Healthy Outcomes In Caring for End Stage Renal Disease
33. FEEDBACK MECHANISMS INFLUENCING PURINE RIBOTIDE SYNTHESIS*
34. How strong are patients’ preferences in choices between dialysis modalities and doses?
35. Cost-quality trade-offs in dialysis care: A national survey of dialysis facility administrators
36. Timing of nephrologist referral and arteriovenous access use: The CHOICE Study
37. In Reply
38. U.S. NEPHROLOGISTS??? ATTITUDES TOWARDS RENAL TRANSPLANTATION: RESULTS FROM A NATIONAL SURVEY
39. Developing a Health-Related Quality-of-Life Measure for End-Stage Renal Disease: The CHOICE Health Experience Questionnaire
40. US nephrologists’ recommendation of dialysis modality: Results of a national survey
41. Use of Focus Groups to Identify Concerns about Dialysis
42. Effects of Acute and Repeated Oral Doses ofd-Tagatose on Plasma Uric Acid in Normal and Diabetic Humans
43. Health Promotion for End-Stage Renal Disease Patients
44. Assessing health and quality of life outcomes in dialysis: A report on an institute of medicine workshop
45. Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting: Committee Statement
46. Influence of circulating insulin-like growth factor-I compared with that of intrarenal insulin-like growth factor-I on proximal nephron receptor density in rats
47. MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
48. Experience with a needleless vascular access device (Hemasite) for hemodialysis.
49. Schizophrenia and Dialysis.
50. Bretylium kinetics in renal insufficiency.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.